Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Invacare acquisitions

This article was originally published in The Gray Sheet

Executive Summary

Invacare acquisitions: Home medical equipment firm expands presence in U.K. through $5.1 mil. cash purchase of Bencraft Limited, a Birmingham, England-based manufacturer of powered and manual wheelchairs. Bencraft had about $10 mil. in sales for its fiscal year ended March 21. Invacare also recently purchased Patient Solutions, Inc., which has a four-modality infusion pump that gives Invacare "a totally new product line that many of our existing DME [durable medical equipment]/respiratory provider customers will purchase as they diversify into home infusion therapy." PSI's pump can provide intravascular feeding, intermittent antibiotic therapy, patient-controlled analgesia and chemotherapy. Privately held with about $1-2 mil. in annual sales, PSI will continue to operate out of its San Diego headquarters under current management led by President Dave Davis...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004299

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel